Chuck Cleland
Charles M. Cleland, PhD
CDUHR - Co-Director, Transdisciplinary Research Methods Core
NYU Langone Health - Associate Professor, Department of Population Health
PhD, Psychology, New School for Social Research
MA, Psychology, New School for Social Research
BA, Psychology, Hampden-Sydney College

Research Interests
HIV prevention, Health disparities, Substance use, Sexual health, Longitudinal data analysis
Charles Cleland is a quantitative psychologist and biostatistician with more than ten years of experience in the field of public health research. His methodological interests include longitudinal data analysis, meta­-analysis, respondent­ driven sampling, and multilevel modeling. His substantive research interests include health disparities, particularly in the areas of substance use and infectious disease.


Jiang N, Xu S, Li L, Cleland CM, Niaura RS (2023).
Use of electronic nicotine delivery system (ENDS) devices among U.S. youth and adults: Findings from the Population Assessment of Tobacco and Health Study waves 1-5
Addictive Behaviors, 139, 107588. doi: 10.1016/j.addbeh.2022.107588. PMCID: PMC9840694.

Feelemyer J, Des Jarlais D, Nagot N, Huong DT, Oahn KTH, Khue PM, Giang HT, Thanh NTT, Cleland CM, Arasteh K, Caniglia E, Chen Y, Bart G, Moles JP, Vinh VH, Vallo R, Quillet C, Rapoud D, Le SM, Michel L, Laureillard D, Khan MR (2023).
Association between recent methamphetamine use, antiretroviral therapy and HIV viral load; a mediation analysis from a cohort of HIV positive persons who inject drugs in Hai Phong, Vietnam
International Journal of STD and AIDS [Epub 2023 Jan 13]. doi: 10.1177/09564624221142366.

Dunn Navarra AM, Rosenberg MG, Gormley M, Bakken S, Fletcher J, Whittemore R, Gwadz M, Cleland C, Melkus GD (2022).
Feasibility and acceptability of the Adherence Connection Counseling, Education, and Support (ACCESS) Proof of Concept: A peer-led, mobile health (mHealth) cognitive behavioral antiretroviral therapy (ART) adherence intervention for HIV-infected (HIV+) adolescents and young adults (AYA)
AIDS and Behavior [Epub 2022 Dec 27]. doi: 10.1007/s10461-022-03913-0. PMCID: PMC9792943 .

Stone J, Fraser H, Walker JG, Mafirakureva N, Mundia B, Cleland C, Kigen B, Musyoki H, Waruiru W, Ragi A, Bhattacharjee P, Chhun N, Lizcano J, Akiyama MJ, Cherutich P, Wisse E, Kurth A, Luhmann N, Vickerman P (2022).
Modelling the impact of HIV and HCV prevention and treatment interventions among people who inject drugs in Kenya
AIDS, 36 (15), 2191-2201. doi: 10.1097/QAD.0000000000003382. PMCID: PMC9671825.

Stevens ER, Xu S, Niaura R, Cleland CM, Sherman SE, Mai A, Karey E, Jiang N (2022).
Youth e-cigarette use and functionally important respiratory symptoms: The Population Assessment of Tobacco and Health (PATH) Study Waves 3 and 4
International Journal of Environmental Research and Public Health, 19 (22), 15324. doi: 10.3390/ijerph192215324. PMCID: PMC9690418.


Kurth AE, Spielberg F, Cleland CM, Lambdin B, Bangsberg DR, Frick PA, Severynen AO, Clausen M, Norman RG, Lockhart D, Simoni JM, Holmes KK (2014).
Computerized counseling reduces HIV-1 viral load and sexual transmission risk: Findings from a randomized controlled trial
Journal of Acquired Immune Deficiency Syndromes, 65 (5), 611-620. doi: 10.1097/QAI.0000000000000100. PMCID: PMC3999203.

Marsch LA, Guarino H, Acosta M, Aponte-Melendez Y, Cleland C, Grabinski M, Brady R, Edwards J (2014).
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
Journal of Substance Abuse Treatment, 46 (1), 43-51. doi: 10.1016/j.jsat.2013.08.012. PMCID: PMC3839618 .

Rosenblum A, Joseph H, Fong, C, Kipnis S, Cleland CM, Portenoy RK (2003).
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities
Journal of the American Medical Association, 289 (18), 2370-2378. doi: 10.1001/jama.289.18.2370.

Dr. Cleland's Research Gate Profile
Selected Press